Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CERo Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERO
)
1.800
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
105,479
Open
1.820
Bid (Size)
1.780 (1)
Ask (Size)
1.840 (3)
Prev. Close
1.800
Today's Range
1.760 - 1.890
52wk Range
1.700 - 1,238.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CERo Therapeutics Holdings, Inc. Highlights Progress
February 06, 2025
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
February 05, 2025
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Performance
YTD
-70.49%
-70.49%
1 Month
-35.71%
-35.71%
3 Month
-90.38%
-90.38%
6 Month
-87.84%
-87.84%
1 Year
-99.63%
-99.63%
More News
Read More
Friday's after hours session: top gainers and losers
January 24, 2025
Via
Chartmill
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split
January 06, 2025
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 18, 2024
Via
Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
December 18, 2024
Via
Benzinga
CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO
December 06, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 15, 2024
Via
Benzinga
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
November 15, 2024
Via
Benzinga
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
November 15, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Why Domino's Pizza Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
November 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 12, 2024
Via
Benzinga
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 11, 2024
Via
Benzinga
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
November 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
CERo Therapeutics Stock Is Soaring Monday: What's Going On?
November 11, 2024
Via
Benzinga
Nasdaq Moves Lower; Canaan Shares Surge
November 11, 2024
Via
Benzinga
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
November 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
November 11, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
CERo Therapeutics, Inc. Provides Corporate Update
October 21, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 09, 2024
Via
Benzinga
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
October 02, 2024
From
CERo Therapeutics Holdings, Inc.
Via
GlobeNewswire
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
September 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.